neurizon ApS: Financial statements 2017
CVR: 36889845
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
neurizon ApS (CVR 36889845) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 562 and a net result of DKK -3,326 compared with DKK -17,167 the year before. Equity in the 2017 report amounted to DKK 30,291. The solvency ratio was 83.5%.
- Gross Profit
- DKK 562
- Profit/Loss
- DKK -3,326
- Equity
- DKK 30,291
- Total Assets
- DKK 36,296
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 562 | -3 t. | 30 t. | - |
| 2016 | - | -13 t. | -17 t. | 34 t. | - |
Official annual report
Keep an eye on neurizon ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Neurizon ApS has published its annual report for 2016. Gross profit came to DKK -13,194, and the net result was DKK -17,167.
About neurizon ApS
neurizon ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kaare Stenhøj Meier. The board consists of Jens Christian Hedemann Sørensen (chair), Kaare Stenhøj Meier, Mattias karl Johan Valdemar Rasmusson and Morten Flink. The company's owners include ITMEDICO HOLDING ApS, KYNOS ApS and Neurologic Holding ApS. In 2025, the company reported a gross profit of DKK 4,175 and a net result of DKK 1,642 compared with DKK -585 the year before. Equity in the 2025 report amounted to DKK 92,461.